As experts in medical imaging and cardiac safety testing for clinical trials, the hard-working people at BioTel Research provide the ideal combination of personal service, global reach, scientific expertise, and on-time data delivery.

45,000 RECORDS
Number of study subjects in largest clinical trial

6/23/70/165
6 continents, 23 time zones, 70 countries, 165 languages

BIG DATA
Part of the world’s largest cardiac data network

2,000 TRIALS
Conducted by BioTel Research, in all therapeutic areas

350 TRIALS
Actively under management (PH I-IV)

9 YEARS
Longest study duration

The Medical Imaging Expertise of VirtualScopics

Now offering the expertise of VirtualScopics, BioTel Research provides comprehensive medical imaging services for clinical trials, including all major modalities for Oncology, Cardiovascular, Musculoskeletal, Neurologic, and imaging for Metabolic Diseases. MORE

The Cardiac Safety Leadership of Cardiocore

BioTel Research, formerly Cardiocore, has been a leader in the cardiac core lab industry since the 1990s. Now, we continue to offer comprehensive, global services, including ECG, Event, Blood Pressure, and Holter monitoring, as well as ECHO and MUGA studies for clinical trials. MORE

What's New

Event

Heart Rhythm Scientific Sessions (HRS 2018)

Visit BioTelemetry, Inc. at booth #543 the HRS 39th Annual Scientific Sessions to learn more about the latest advancements in cardiac monitoring patch technology from BioTel Heart: MCOT Patch and ePatch.

May 9-12, 2018

Event

Clinical Operations in Oncology Trials West Coast

Stop by booth #26 to meet with our VP of Oncology Imaging, Ed Ashton, PhD, to learn more about response assessment in Immune-Oncology.

April 24-25, 2018

Webinar

Body Composition in Clinical Trials – From BMI to MRI

In this free webinar, BioTel Research’s Vice President of Musculoskeletal and Metabolic Imaging, Jonathan Riek, PhD, and AMRA’s Chief Scientific Officer & Co-Founder, Olof Dahlqvist Leinhard, PhD, present alternative, noninvasive imaging methods to determine body composition.

Feb 13, 2018 | 11:00 AM

White Paper

Exploring Immunotherapies: Beyond Checkpoint Inhibitors

Immunotherapy is an emerging class of cancer treatment, which stimulates the body’s immune system to fight cancer. With the approval of three checkpoint inhibitors (ipilimumab, pembrolizumab and nivolumab) by the FDA in the past five years, immunotherapies are seen as exciting treatments able to elicit durable cures. Download our white paper to discover: Emerging immunotherapeutic […]

Jun 1, 2016

Blog

Blood Pressure Evaluation During Early Phase Trials

As we know, more attention is being paid to blood pressure (BP) effects in new chemical entities under development for non-hypertension indications, especially when these are not anticipated or thoroughly defined during drug development. Discovering negative results for BP elevation in early trials, would allow more informed planning for BP safety monitoring in later trials. Download […]

Nov 3, 2014

Contact BioTel Research

Inquiries

GENERAL INQUIRIES:
Toll-Free: 1.877.267.3324
Local: 1.301.214.7600
Fax: 1.301.214.7601
BTRinfo@gobio.com

BUSINESS DEVELOPMENT:
Local: 1.301.214.7628
BTRbusiness@gobio.com

CLINICAL TRIALS SUPPORT:
Toll Free: 1.877.324.8326
BTRsupport@gobio.com

USA Offices

GLOBAL HEADQUARTERS:
One Preserve Parkway
Suite 600
Rockville, MD 20852
USA

NEW ENGLAND:
155 Corporate Woods
Suite 180
Rochester, NY 14623
USA

WEST COAST:
400 Oyster Point Blvd
Suite 339
South San Francisco, CA 94080
USA

International Offices

EUROPE:
Building 3 Chiswick Park
Suite 258
566 Chiswick High Road
London, W4 5YA
UK

ASIA-PACIFIC:
Kabutocho Daiichi Heiwa
Bldg. 3F
5-1 Nihonbashi-Kabutocho
Chuo-ku
Tokyo 103-0026
JAPAN

On LinkedIn

Connect with Us for the latest on our clinical trials services, including medical imaging and cardiac safety testing